APLNR and glioblastoma: Knocking out APJ in glioblastoma cells reduced tumor growth and angiogenesis, suggesting that targeting the apelin/APJ system is a promising strategy for preventing angiogenesis in glioblastoma (Amoozgar et al., 2019; Frisch et al., 2020).